Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Kazuhito Miyachi"'
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 42:687-691
Autor:
Eigo, Kurayama, Kinro, Sasaki, Hitoshi, Satomura, Haruka, Yokoyama, Maiko, Kikuchi, Tsukasa, Kubo, Nozomi, Ueno, Kichiro, Otsuka, Shinichi, Onodera, Jun, Ito, Masanobu, Nakajima, Satoru, Yamaguchi, Kazuhito, Miyachi, Takashi, Tsuchioka, Hiroyuki, Kato
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(10)
A 41-year-old woman with type 3 advanced gastric cancer and Virchow lymph node, para-aortic lymph node, and multiple bone metastases was diagnosed with U-less cType 3 cT4aN3M1, cStage IV. We administered docetaxel, cisplatin, and S-1 (DCS)therapy for
Autor:
Shinichi Onodera, Kinro Sasaki, Satoru Yamaguchi, Norihito Yoda, Masakatsu Sunagawa, Kazuhito Miyachi, Kichiro Otsuka, Hiroyuki Kato, Hitoshi Satomura, Masanobu Nakajima
Publikováno v:
World Journal of Surgery. 39:1127-1133
Billroth-I (BI) is a simple, physiological method of reconstruction following distal gastrectomy. In actuality, postoperative QOL is by no means favorable due to the high incidence of post-gastrectomy syndrome. The aim of this study is to assess the
Autor:
Jun Ito, Shinichi Onodera, Hiroyuki Kato, Eigo Kurayama, Masanobu Nakajima, Satoru Yamaguchi, Kazuhito Miyachi, Kinro Sasaki, Masakazu Takahashi, Kichiro Otsuka, Tsukasa Kubo, Hitoshi Satomura
Publikováno v:
Medical oncology (Northwood, London, England). 34(8)
Gastrectomy with D2 lymphadenectomy plus postoperative chemotherapy is the standard treatment for resectable locally advanced gastric cancer in Japan. However, the prognosis of patients with serosa-positive tumors remains unsatisfactory because of pe
Autor:
Akira Sugawara, Hiroto Muroi, Kazuhito Miyachi, Hiroyuki Kato, Masanobu Nakajima, Keisuke Ihara
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75:1527-1531
Autor:
Masakazu Yamamoto, Kazuhito Miyachi, Kyoji Ogoshi, Hitoshi Katai, Shojiro Kikuchi, Yoshito Komatsu, Yoshihiro Kakeji, Atsushi Ohtsu, Toshirou Nishida, Akira Sawaki, Seiichi Hirota, Tatsuo Kanda, Toshihiko Doi, Masato Koseki, Toshiro Sugiyama, Norihito Wada, Yasushi Toh, Osamu Kobayashi, Narikazu Boku
Publikováno v:
International Journal of Clinical Oncology. 18:38-45
Imatinib mesylate, a small-molecule tyrosine kinase inhibitor, is currently used for adjuvant therapy of patients who have undergone resection of high-risk gastrointestinal stromal tumors (GISTs). There are no data concerning the efficacy and safety
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72:2448-2454
Autor:
Yasushi Domeki, Shinichi Onodera, Yuuichi Itoh, Hiroyuki Kato, Masakazu Takahashi, Masanobu Nakajima, Norihito Yoda, Kazuhito Miyachi, Yousuke Shida, Kei Kaneko, Kichiro Ootsuka, Kinro Sasaki
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72:1091-1096
早期胃癌に対する腹腔鏡補助下幽門側胃切除術(LADG)は広く普及してきている.教室においてLADGが施行された早期胃癌100例を対象とし,同時期に行われた開腹幽門側胃切除術(ODG)76例
Publikováno v:
Dokkyo journal of medical sciences. 35(1):13-17
The usefulness of histoculture drug response assay (HDRA) before the start of antitumor chemotherapy was explored to predict the antitumor response of chemotherapy for progressive gastric cancer patients with hepatic metastasis. Cancer tissue was col
Autor:
Tetsuya, Ohkawa, Kazuhito, Miyachi
Publikováno v:
Dokkyo journal of medical sciences. 33(1):25-34
Angiogenesis is a key process in tumor growth and metastasis. In 27 patients with advanced gastric carcinoma before operation and 9 healthy controls, plasma levels of endostatin (ES), cathepsin L (Cat-L) and soluble VEGF R1/Flt-1 (sVEGF R1), which ar